(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Former Name or Former Address, if Changed Since Last Report) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Ticker symbol(s) | Name of each exchange on which registered | ||||||||||||
Not Applicable. | Not Applicable. | Not Applicable. |
Exhibit No. | Description | |||||||
99.1 * | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
MARIMED INC. | ||||||||
Dated: November 3, 2023 | ||||||||
By: | /s/ Jon R. Levine | |||||||
Jon R. Levine, President and Chief Executive Officer |
Cover |
Oct. 31, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Oct. 31, 2023 |
Entity Registrant Name | MARIMED INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 0-54433 |
Entity Tax Identification Number | 27-4672745 |
Entity Address, Address Line One | 10 Oceana Way |
Entity Address, City or Town | Norwood |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02062 |
City Area Code | (781) |
Local Phone Number | 277-0007 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001522767 |
Amendment Flag | false |
RHY_U=3_ 102P,$% @ 8#QC5Y>*NQS $P( M L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/: (7->=I3W;+T]!;X"O.DQQ0FE( M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'B4?'D78FYJ MD6:>IK&HP=MX1PT$G53$WHI"/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H M!"DHV1%[A$O\G7 D(G MP&LK\,S4-AB.G8RF2&]B]#V,YU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28) MUD-N5G0&[O+H YMRR"9JZJ8IGJ,.>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z M_S!YU!Y:YU;*O8=7LN48Y0]02P,$% @ 8#QC5R0>FZ*M ^ $ M !H !X;"]? +7_OR4Z?:!1W;J"V\R1&:P;* M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( & \8U=ED'F2&0$ M ,\# 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@ MIAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1 M?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI M>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UP MZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T M,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^ MD &PO=&AE;64O=&AE;64Q M+GAM;%!+ 0(4 Q0 ( & \8U==ZSPRYP, "\/ 8 " M@0P( !X;"]W;W)K &PO 7BKL JQ"(6,P$ "(" / M " >X/ !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " !@/&-7)!Z; MHJT #X 0 &@ @ %.$0 >&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'-02P$"% ,4 " !@/&-799!YDAD! #/ P $P M @ $S$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" !] %$P ! end
IRI;0T
MCY0<5T&EL@GR+^Z5KFD *2WVS(FE5Z((
MG3\Z(R+@--&7A5XZ_[I;&Z9Z$?]E!U**#]K$0QBMVWTA]91^3/D+29#=&?/U
M)K&J!3SAIY8Q5:5'. 3BM;SLK;A_+;'I3>0$,PK79
M^MWR! E*0L)BP(G@ $$2 192'^ 0DA@%$<)^]'9Z$B12",XB0!#49F$,$LXD
M@ (QA+A( HIKI[,L_^M$_Y>PA?14>/FB_O7#Z*:J;D_&X_O[^W23E[5Y33
M<0!A.%Y;CU;F#SOV]V%M[5-*Q_6[3Z:+S&2HW/KC/W^_N.(W